Why the study?
Cardiovascular disease is a competing cause of death in cancer patients, and effective strategies like cardiac rehabilitation are needed to mitigate this risk.
Does cardio-oncology rehabilitation mitigate cardiovascular disease risk in cancer patients and survivors?
Does cardio-oncology rehabilitation mitigate cardiovascular disease risk in cancer patients and survivors?
This AHA scientific statement introduces the concept of cardio-oncology rehabilitation to address the unique cardiovascular risks and complications related to cancer care.
Answers are grounded in this paper and cite their sources.
Provides framework for cardio-oncology rehab infrastructure; leaves open randomized confirmation of CVD risk mitigation.
Cardiovascular disease is a competing cause of death in patients with cancer with early-stage disease. This elevated cardiovascular disease risk is thought to derive from both the direct effects of cancer therapies and the accumulation of risk factors such as hypertension, weight gain, cigarette smoking, and loss of cardiorespiratory fitness. Effective and viable strategies are needed to mitigate cardiovascular disease risk in this population; a multimodal model such as cardiac rehabilitation may be a potential solution. This statement from the American Heart Association provides an overview of the existing knowledge and rationale for the use of cardiac rehabilitation to provide structured exercise and ancillary services to cancer patients and survivors. This document introduces the concept of cardio-oncology rehabilitation, which includes identification of patients with cancer at high risk for cardiac dysfunction and a description of the cardiac rehabilitation infrastructure needed to address the unique exposures and complications related to cancer care. In this statement, we also discuss the need for future research to fully implement a multimodal model of cardiac rehabilitation for patients with cancer and to determine whether reimbursement of these services is clinically warranted.
No takes yet. Share an insight, caveat, or question.
Gilchrist et al. (2019) conducted a review in Cardiovascular disease risk and cardiac dysfunction in cancer patients and survivors. Cardio-oncology rehabilitation (multimodal cardiac rehabilitation) was evaluated. Cardio-oncology rehabilitation is proposed as a multimodal strategy to provide structured exercise and ancillary services to mitigate cardiovascular disease risk in cancer patients and survivors.
Synapse has enriched 10 related papers. Consider them for comparative context: